OVAS

Ovascience Inc. (delisted) (OVAS)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:OVAS
DataOraFonteTitoloSimboloCompagnia
13/12/201822:09Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OVASOvascience Inc. (delisted)
13/12/201815:01Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:OVASOvascience Inc. (delisted)
07/12/201812:01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:OVASOvascience Inc. (delisted)
30/11/201812:04Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:OVASOvascience Inc. (delisted)
30/11/201812:02Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:OVASOvascience Inc. (delisted)
28/11/201823:29Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)NASDAQ:OVASOvascience Inc. (delisted)
09/11/201823:32Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:OVASOvascience Inc. (delisted)
07/11/201821:58Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:OVASOvascience Inc. (delisted)
06/11/201823:34Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:OVASOvascience Inc. (delisted)
06/11/201812:06Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (definitive) (defm14a)NASDAQ:OVASOvascience Inc. (delisted)
05/11/201821:52Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:OVASOvascience Inc. (delisted)
05/11/201812:04Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:OVASOvascience Inc. (delisted)
01/11/201821:01Business WireOvaScience and Millendo Therapeutics Provide Update on Merger Agreement and FinancingNASDAQ:OVASOvascience Inc. (delisted)
26/10/201815:02Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:OVASOvascience Inc. (delisted)
03/10/201800:05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OVASOvascience Inc. (delisted)
27/09/201800:21Edgar (US Regulatory)Securities Registration: Business Combination (s-4)NASDAQ:OVASOvascience Inc. (delisted)
09/08/201823:31Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:OVASOvascience Inc. (delisted)
09/08/201822:01Business WireOvaScience Reports Second Quarter 2018 Financial Results and Provides Strategic Alternatives UpdateNASDAQ:OVASOvascience Inc. (delisted)
09/08/201813:00Business WireOvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease CompanyNASDAQ:OVASOvascience Inc. (delisted)
03/05/201823:23Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:OVASOvascience Inc. (delisted)
03/05/201822:01Business WireOvaScience Reports First Quarter 2018 Financial Results and Provides Business UpdateNASDAQ:OVASOvascience Inc. (delisted)
30/04/201823:11Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:OVASOvascience Inc. (delisted)
10/04/201816:13Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:OVASOvascience Inc. (delisted)
15/03/201821:28Edgar (US Regulatory)Annual Report (10-k)NASDAQ:OVASOvascience Inc. (delisted)
15/03/201821:17Edgar (US Regulatory)Withdrawal of Registration Statement (rw)NASDAQ:OVASOvascience Inc. (delisted)
15/03/201821:01Business WireOvaScience Reports Fourth Quarter and Year-End 2017 Financial ResultsNASDAQ:OVASOvascience Inc. (delisted)
12/03/201821:02Business WireOvaScience Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:OVASOvascience Inc. (delisted)
08/03/201822:02Business WireOvaScience to Host Fourth Quarter and Fiscal Year 2017 Financial Results Conference CallNASDAQ:OVASOvascience Inc. (delisted)
22/01/201823:32Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:OVASOvascience Inc. (delisted)
04/01/201813:00Business WireOvaScience to Present at the 36th Annual J.P. Morgan Healthcare ConferenceNASDAQ:OVASOvascience Inc. (delisted)
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:OVAS
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network